(Q35206939)

7 August 2017

1 reference

title

Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system (English)

1 reference

7 August 2017

0 references

endocannabinoid system

0 references

1 reference

1

Benjamin F Cravatt

1 reference

7 August 2017

Aron H Lichtman

2

1 reference

7 August 2017

1 August 2003

1 reference

Current Opinion in Chemical Biology

7 August 2017

1 reference

7 August 2017

7

1 reference

7 August 2017

4

1 reference

7 August 2017

469-475

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Lysophospholipid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

2-Arachidonoylglycerol and the cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

An anorexic lipid mediator regulated by feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Chemical characterization of a family of brain lipids that induce sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Catabolism of N-acylethanolamine phospholipids by dog brain preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Pharmacological actions and therapeutic uses of cannabis and cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

The functional neuroanatomy of brain cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Pathobiology of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Discovering potent and selective reversible inhibitors of enzymes in complex proteomes

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

A missense mutation in human fatty acid amide hydrolase associated with problem drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Endocannabinoid signaling in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

Monoamine transporter pharmacology and mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900079-6

7 January 2021

10.1016/S1367-5931(03)00079-6

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12941421